Return On Assets in % of Spyre Therapeutics, Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Spyre Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q3 2016 to Q3 2025.
  • Spyre Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -26.8 %, a 47.4% increase year-over-year.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2024 was -42.6 %, a 73.4% increase from 2023.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2023 was -160 %, a 68.6% decline from 2022.
  • Spyre Therapeutics, Inc. annual Return On Assets for 2022 was -95.1 %, a 98.5% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Spyre Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26.8 +24.2 +47.4% 01 Jul 2025 30 Sep 2025
Q2 2025 -38.7 +11.8 +23.4% 01 Apr 2025 30 Jun 2025
Q1 2025 -41.1 +72.7 +63.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -42.6 +118 +73.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -51 +154 +75.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -50.5 +187 +78.7% 01 Apr 2024 30 Jun 2024
Q1 2024 -114 -17.1 -17.7% 01 Jan 2024 31 Mar 2024
Q4 2023 -160 -65.3 -68.6% 01 Oct 2023 31 Dec 2023
Q3 2023 -205 -118 -135% 01 Jul 2023 30 Sep 2023
Q2 2023 -238 -156 -191% 01 Apr 2023 30 Jun 2023
Q1 2023 -96.7 -35.3 -57.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -95.1 -47.2 -98.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -87.3 -42 -92.8% 01 Jul 2022 30 Sep 2022
Q2 2022 -81.6 -39.7 -94.7% 01 Apr 2022 30 Jun 2022
Q1 2022 -61.4 -12.2 -24.8% 01 Jan 2022 31 Mar 2022
Q4 2021 -47.9 +10.4 +17.9% 01 Oct 2021 31 Dec 2021
Q3 2021 -45.3 +21.6 +32.3% 01 Jul 2021 30 Sep 2021
Q2 2021 -41.9 +37.2 +47% 01 Apr 2021 30 Jun 2021
Q1 2021 -49.2 +38.2 +43.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -58.3 +14.6 +20% 01 Oct 2020 31 Dec 2020
Q3 2020 -66.9 +0.74 +1.09% 01 Jul 2020 30 Sep 2020
Q2 2020 -79.1 -16.3 -25.9% 01 Apr 2020 30 Jun 2020
Q1 2020 -87.3 -27.6 -46.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -72.9 -9.22 -14.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -67.6 -11.7 -20.9% 01 Jul 2019 30 Sep 2019
Q2 2019 -62.8 -10.9 -21.1% 01 Apr 2019 30 Jun 2019
Q1 2019 -59.8 -9.92 -19.9% 01 Jan 2019 31 Mar 2019
Q4 2018 -63.7 -19.2 -43.2% 01 Oct 2018 31 Dec 2018
Q3 2018 -56 -15 -36.5% 01 Jul 2018 30 Sep 2018
Q2 2018 -51.8 -15.1 -40.9% 01 Apr 2018 30 Jun 2018
Q1 2018 -49.9 -16.2 -47.9% 01 Jan 2018 31 Mar 2018
Q4 2017 -44.5 -10 -29.1% 01 Oct 2017 31 Dec 2017
Q3 2017 -41 -4.85 -13.4% 01 Jul 2017 30 Sep 2017
Q2 2017 -36.8 01 Apr 2017 30 Jun 2017
Q1 2017 -33.7 01 Jan 2017 31 Mar 2017
Q4 2016 -34.5 01 Oct 2016 31 Dec 2016
Q3 2016 -36.2 01 Jul 2016 30 Sep 2016

Spyre Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -42.6 +118 +73.4% 01 Jan 2024 31 Dec 2024
2023 -160 -65.3 -68.6% 01 Jan 2023 31 Dec 2023
2022 -95.1 -47.2 -98.5% 01 Jan 2022 31 Dec 2022
2021 -47.9 +10.4 +17.9% 01 Jan 2021 31 Dec 2021
2020 -58.3 +14.6 +20% 01 Jan 2020 31 Dec 2020
2019 -72.9 -9.22 -14.5% 01 Jan 2019 31 Dec 2019
2018 -63.7 -19.2 -43.2% 01 Jan 2018 31 Dec 2018
2017 -44.5 -10 -29.1% 01 Jan 2017 31 Dec 2017
2016 -34.5 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.